| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,125 |
6,107 |
$278K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,214 |
2,641 |
$261K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,065 |
2,624 |
$98K |
| 93880 |
|
1,965 |
1,690 |
$93K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
755 |
638 |
$68K |
| 93000 |
|
4,535 |
3,889 |
$48K |
| 93224 |
|
95 |
69 |
$18K |
| 94729 |
|
700 |
590 |
$14K |
| 94060 |
|
693 |
578 |
$14K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
350 |
197 |
$14K |
| 99490 |
Ccm add 20min |
3,843 |
3,743 |
$13K |
| 94727 |
|
654 |
545 |
$10K |
| 99406 |
|
1,318 |
1,153 |
$10K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
842 |
698 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
258 |
132 |
$9K |
| 80061 |
Lipid panel |
1,719 |
1,539 |
$9K |
| 94070 |
|
166 |
149 |
$7K |
| 93015 |
|
252 |
152 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
101 |
72 |
$4K |
| 94016 |
|
260 |
232 |
$3K |
| 93225 |
|
93 |
83 |
$2K |
| 94200 |
|
412 |
351 |
$2K |
| 93227 |
|
93 |
82 |
$2K |
| 94760 |
|
332 |
267 |
$2K |
| 99226 |
|
29 |
26 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
30 |
24 |
$1K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
159 |
56 |
$1K |
| 93296 |
|
116 |
97 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
57 |
38 |
$1K |
| 82043 |
|
233 |
206 |
$852.15 |
| 82570 |
|
226 |
202 |
$725.40 |
| 80053 |
Comprehensive metabolic panel |
169 |
151 |
$612.24 |
| 93228 |
|
46 |
44 |
$601.84 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28 |
28 |
$562.54 |
| 81003 |
|
378 |
343 |
$549.48 |
| 94618 |
|
42 |
33 |
$490.43 |
| 84460 |
|
461 |
425 |
$447.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
62 |
55 |
$397.09 |
| 84450 |
|
458 |
421 |
$380.22 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,455 |
1,322 |
$379.90 |
| 36415 |
Collection of venous blood by venipuncture |
1,710 |
1,571 |
$357.30 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48 |
22 |
$355.84 |
| 83718 |
|
29 |
29 |
$298.70 |
| 93701 |
|
31 |
26 |
$246.65 |
| APT03 |
|
28 |
28 |
$234.08 |
| 83735 |
|
30 |
28 |
$141.42 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
12 |
$116.04 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
30 |
25 |
$94.97 |
| 93294 |
|
17 |
12 |
$92.51 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13 |
13 |
$85.93 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
117 |
42 |
$18.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
14 |
$16.42 |
| G9275 |
Documentation that patient is a current non-tobacco user |
422 |
374 |
$0.22 |
| 1036F |
|
366 |
325 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
27 |
24 |
$0.00 |
| 99443 |
|
29 |
15 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
182 |
164 |
$0.00 |
| 4004F |
|
197 |
176 |
$0.00 |
| 99487 |
Ccm add 20min |
28 |
26 |
$0.00 |